An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Clinical trial NCT07324889 · NOT_YET_RECRUITING

Trial details

NCT number

NCT07324889

Sponsor

Yihao Wang

Status

NOT_YET_RECRUITING

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2026-01-31

Primary completion

2027-10-31

Enrollment

24

View on ClinicalTrials.gov